Fig. 9

TMED3 promotes malignant proliferation of PCa cells. A Distribution of mRNA expression across different cell lines. B Distribution of protein expression in normal prostate and PCa tissues obtained from the HPA database. C Efficiency of TMED3 knockdown in LNCaP and VCaP cells. D CCK-8 assay measuring cell viability in LNCaP and VCaP cells. E Colony formation assay assessing the colony-forming ability of LNCaP and VCaP cells. F EdU assay evaluating cell proliferation in LNCaP and VCaP cells. G Apoptosis analysis of LNCaP and VCaP cells using flow cytometry. *P < 0.05, **P < 0.01, ***P < 0.001